Obesity Can Make Multiple Sclerosis Medications Less Effective

Lemtrada Stroke Lawsuit News

Being overweight can lead not only to a host of serious diseases but also make the treatment of relapse remitting multiple sclerosis less effective

Wednesday, October 2, 2019 - Obesity can make multiple sclerosis (MS) more painful and worsen the condition. Studies show that morbidly overweight people have twice as many MS relapses as those who maintain a healthy weight. Such a dramatic deterioration in condition should come as no surprise as obesity causes Lemtrada patients to fail to metabolize the drug as effectively as patients who are at a healthy weight. Also, younger people who are overweight respond more poorly to first-line treatments making Lemtrada treatments a necessity. Obesity can be attributed to children having an increased risk of developing childhood multiple sclerosis. Lemtrada has a severely adverse safety profile that makes taking the drug treatment of last resort. Incredibly, overweight diabetic patients were twice as likely to have to switch to a stronger medication than those that were of normal weight. Lemtrada stroke lawsuit attorneys represent people and families in the United States and offer a free consultation and no obligation to file a claim.

While we're on the subject, obesity can lead to other serious illnesses and perhaps even contribute to the onset of multiple sclerosis. Studies prove that being overweight more than quadruples a person's likelihood of developing diabetes, one of the most serious illnesses known to man. According to ManagedCareMag.com, "Obese adults between the ages of 25 and 64 are at least four times more likely to have been diagnosed with diabetes than are those with a normal weight, according to a new Gallup survey. By their middle to late 30's, 9.3% of adults who are obese have been diagnosed with diabetes compared with 1.8% of those who are normal weight." Obesity also can lead to high blood pressure, hypertension, and other cardiovascular diseases as well.

Relapse remitting multiple sclerosis (RRMS) is the most common form of MS that is defined by patients that have MS symptoms followed by periods of remission. The disease is a chronic condition where the sheathing of the nerves are destroyed making them fire off uncontrollable. RRMS patients gradually suffer from symptoms that increase in severity and frequency. Patients that fail to respond to traditional treatment for alleviating MS symptoms may wish to take Lemtrada which is highly effective but also causes severe life-threatening complications such as permanent paralysis from strokes and sudden death from a heart attack. RRMS patients are given Lemtrada in two, one-week infusions, for two years. In addition to strokes and heart attack, Lentrada causes "serious autoimmune problems and kidney failure that needs dialysis, a kidney transplant, or death," according to the warning on Lemtrada.com. Lemtrada patients that are not affected by the side effects are thrilled with the outcomes as the drug extends the period between multiple sclerosis relapses and lessens the relapse's severity. A patient must look to improving their diet and exercise routines and losing weight, and not just taking medication, as therapy for controlling RRMS symptoms.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.